Intrapulmonary Concentrations of Telithromycin: Clinical Implications for Respiratory Tract Infections due to Streptococcus pneumoniae

Publisher： Karger

E-ISSN： 1421-9794|51|6|339-346

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.6, 2005-11, pp. : 339-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time-Kill Kinetics of Streptococcus pneumoniae with Reduced Susceptibility to Telithromycin

By  

Chemotherapy, Vol. 53, Iss. 3, 2007-03 ,pp. : 190-193

Karger

Access to resources Recommend Favorite

Ten-Year Trends and Clinical Relevance of the Antimicrobial Resistance Genotype in Respiratory Isolates of Streptococcus pneumoniae

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-05 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

A Multicenter, Randomized Controlled Clinical Study on Biapenem and Imipenem/Cilastatin Injection in the Treatment of Respiratory and Urinary Tract Infections

By  

Chemotherapy, Vol. 56, Iss. 4, 2010-08 ,pp. : 285-290

Karger

Access to resources Recommend Favorite

Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial

By  

Chemotherapy, Vol. 58, Iss. 3, 2012-08 ,pp. : 249-256

Karger

Access to resources Recommend Favorite

Cefixime in the Treatment of Respiratory and Urinary Tract Infections

By  

Chemotherapy, Vol. 44, Iss. 1, 1998-10 ,pp. : 31-34

Karger

Access to resources Recommend Favorite